DCF — JFK UNIVERSITY MEDICAL CENTER
Enterprise Value: $-784.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-784.4M
Enterprise Value
$-255.5M
PV of Cash Flows
$-528.9M
PV of Terminal Value
$-851.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $709.4M | $-44.9M | -6.0% | $-74.9M | $-68.1M |
| Year 2 | $730.7M | $-38.9M | -5.0% | $-69.8M | $-57.7M |
| Year 3 | $752.6M | $-32.5M | -4.0% | $-64.4M | $-48.4M |
| Year 4 | $775.2M | $-29.6M | -4.0% | $-62.5M | $-42.7M |
| Year 5 | $798.4M | $-28.5M | -4.0% | $-62.3M | $-38.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-784.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$688.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0682355568178509
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5